Evanson Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $290K | Hold |
591
| – | – | 0.02% | 259 |
|
|
2025
Q4 | $342K | Buy |
591
+141
| +31% | +$79.7K | 0.02% | 242 |
|
|
2025
Q3 | $218K | Buy |
+450
| New | +$209K | 0.01% | 309 |
|
|
2025
Q2 | – | Sell |
-435
| Closed | -$216K | – | 338 |
|
|
2025
Q1 | $216K | Sell |
435
-360
| -45% | -$195K | 0.02% | 289 |
|
|
2024
Q4 | $414K | Hold |
795
| – | – | 0.03% | 201 |
|
|
2024
Q3 | $492K | Hold |
795
| – | – | 0.03% | 183 |
|
|
2024
Q2 | $440K | Hold |
795
| – | – | 0.03% | 181 |
|
|
2024
Q1 | $462K | Hold |
795
| – | – | 0.03% | 193 |
|
|
2023
Q4 | $422K | Hold |
795
| – | – | 0.03% | 194 |
|
|
2023
Q3 | $402K | Sell |
795
-400
| -33% | -$213K | 0.04% | 185 |
|
|
2023
Q2 | $623K | Hold |
1,195
| – | – | 0.06% | 137 |
|
|
2023
Q1 | $689K | Hold |
1,195
| – | – | 0.07% | 124 |
|
|
2022
Q4 | $658K | Sell |
1,195
-104
| -8% | -$55.1K | 0.07% | 124 |
|
|
2022
Q3 | $659K | Hold |
1,299
| – | – | 0.08% | 121 |
|
|
2022
Q2 | $706K | Hold |
1,299
| – | – | 0.08% | 116 |
|
|
2022
Q1 | $767K | Hold |
1,299
| – | – | 0.07% | 122 |
|
|
2021
Q4 | $867K | Hold |
1,299
| – | – | 0.08% | 111 |
|
|
2021
Q3 | $660K | Sell |
1,299
-44
| -3% | -$24.1K | 0.07% | 141 |
|
|
2021
Q2 | $678K | Buy |
1,343
+10
| +0.8% | +$4.72K | 0.07% | 136 |
|
|
2021
Q1 | $608K | Buy |
1,333
+20
| +2% | +$9.55K | 0.09% | 140 |
|
|
2020
Q4 | $612K | Buy |
1,313
+189
| +17% | +$88.6K | 0.1% | 133 |
|
|
2020
Q3 | $496K | Hold |
1,124
| – | – | 0.09% | 131 |
|
|
2020
Q2 | $407K | Buy |
1,124
+25
| +2% | +$8.38K | 0.08% | 147 |
|
|
2020
Q1 | $312K | Buy |
1,099
+20
| +2% | +$6.31K | 0.07% | 157 |
|
|
2019
Q4 | $351K | Hold |
1,079
| – | – | 0.07% | 164 |
|
|
2019
Q3 | $314K | Hold |
1,079
| – | – | 0.06% | 173 |
|
|
2019
Q2 | $317K | Hold |
1,079
| – | – | 0.06% | 173 |
|
|
2019
Q1 | $295K | Hold |
1,079
| – | – | 0.06% | 176 |
|
|
2018
Q4 | $241K | Sell |
1,079
-280
| -21% | -$65.7K | 0.06% | 194 |
|
|
2018
Q3 | $332K | Hold |
1,359
| – | – | 0.07% | 170 |
|
|
2018
Q2 | $282K | Hold |
1,359
| – | – | 0.06% | 198 |
|
|
2018
Q1 | $281K | Hold |
1,359
| – | – | 0.06% | 199 |
|
|
2017
Q4 | $258K | Buy |
+1,359
| New | +$260K | 0.05% | 212 |
|
Other funds holding TMO
VCM
Evanson Asset Management's TMO Position: Q1 2026 in Review
Evanson Asset Management held its Thermo Fisher Scientific (TMO) position steady in Q1 2026 at 591 shares worth $290K. The position accounts for 0.02% of the portfolio, ranked #259.
Evanson Asset Management first reported a position in TMO in Q4 2017 and has held it in 33 quarters since. The position peaked at $867K in Q4 2021. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Evanson Asset Management held 591 shares of Thermo Fisher Scientific worth $290K as of Q1 2026.
- Evanson Asset Management left its Thermo Fisher Scientific share count unchanged in Q1 2026.
- Thermo Fisher Scientific made up 0.02% of Evanson Asset Management's portfolio in Q1 2026, its #259 holding.
- Evanson Asset Management first reported a position in Thermo Fisher Scientific in Q4 2017 and has held it in 33 quarters since.
- Evanson Asset Management's Thermo Fisher Scientific position peaked at $867K in Q4 2021.
- 2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Evanson Asset Management's 13F filing for Q1 2026, filed 8 Apr 2026.